Results 151 to 160 of about 114,540 (260)

Disability in pediatric inflammatory bowel diseases: A systematic review and a single center experience

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives Toward development of a pediatric IBD disability index (PIDI), we aimed to review the literature on disability in pediatric inflammatory bowel disease (PIBD) and to estimate disability rates in a pediatric inception cohort. Methods A systematic review identified studies reporting disability in PIBD and in adult randomized controlled
Reut Rappaport   +13 more
wiley   +1 more source

Physician documented fatigue among adults and children with inflammatory bowel disease: a nationwide routinely collected health data study from the epi-IIRN. [PDF]

open access: yesCrohns Colitis 360
Focht G   +11 more
europepmc   +1 more source

Chronic conditions associated with paediatric onset inflammatory bowel diseases: A population‐based study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective Several conditions are associated with inflammatory bowel disease (IBD), including immune‐mediated inflammatory diseases (IMIDs), extraintestinal manifestations (EIMs), and psychiatric disorders. This study aimed to describe at population‐level the comorbidities and their relative burden in paediatric‐onset IBD (pIBD).
Nicolas Richard   +480 more
wiley   +1 more source

Fecal microRNA signatures as non‐invasive diagnostic and prognostic markers of pediatric inflammatory bowel diseases

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objectives The identification of novel noninvasive diagnostic and prognostic biomarkers for pediatric inflammatory bowel disease (PIBD), including pediatric Crohn's disease (pCD) and ulcerative colitis (pUC), is crucial for improving therapeutic outcomes.
Tereza Pinkasova   +11 more
wiley   +1 more source

Fecal microbiota transplantation and microbiota‐based therapeutics in pediatric clinical practice: Current status and emerging indications

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Fecal microbiota transplantation (FMT) is a safe and effective treatment for recurrent or refractory Clostridioides difficile infection (rCDI) in children and adults. This review outlines the evidence behind FMT for rCDI, considerations in special pediatric populations, and limitations in current practice due to FMT access for patients under ...
Nikhil Pai   +3 more
wiley   +1 more source

The hidden burden of sarcopenia in inflammatory bowel disease: a strong predictor of complications. [PDF]

open access: yesFront Gastroenterol (Lausanne)
Guarino AD   +11 more
europepmc   +1 more source

Cumulative incidence of perianal manifestations in pediatric‐onset inflammatory bowel disease: A nationwide Swedish cohort study

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Perianal disease is a recognized complication of pediatric Crohn's disease (CD), but data on ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBD‐U) are limited. We examined the occurrence of perianal disease before, at, and after diagnosis of pediatric‐onset IBD compared with matched (age, sex, and geographical region ...
Åsa H. Everhov   +11 more
wiley   +1 more source

Efficacy and safety of ustekinumab and vedolizumab in very early‐onset inflammatory bowel disease: A multicenter study from the pediatric inflammatory bowel disease Porto Group of ESPGHAN

open access: yesJournal of Pediatric Gastroenterology and Nutrition, EarlyView.
Abstract Objective We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very‐early onset inflammatory bowel disease (VEO‐IBD). Methods A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition ...
Luca Scarallo   +45 more
wiley   +1 more source

Home - About - Disclaimer - Privacy